Le Lézard
Classified in: Health
Subjects: PSF, CFG

Public advisory - Unauthorized prescription and controlled drugs seized from two natural food stores in Sudbury, Ontario, because they may pose serious health risks


OTTAWA, ON, Feb. 20, 2023 /CNW/ - 

Summary

Images

PNF-Vitamin-D3-4000-IU (CNW Group/Health Canada)

Natrix-Dioscorene-Progesterone-Cream (CNW Group/Health Canada)

Paragon-Amore-Exotic-Herbal-Formula (CNW Group/Health Canada)

PNF-Vitamin-D3-4000-IU (CNW Group/Health Canada)

PNF-Vitamin-D3-10000-IU (CNW Group/Health Canada)

Affected products

Product

Promoted use

Prescription drug on the label

Retailer

DHEA (Dehydroepiandrosterone)

 

Workout supplement

Labelled to contain DHEA (dehydroepiandrosterone)

Paris Natural Foods

1500 Paris Street

Sudbury, ON

 

Natrix Nutraceuticals Inc.

Dioscorene Natural Progesterone Cream

 

Hormone replacement therapy

Labelled to contain progesterone

Paris Natural Foods

1500 Paris Street

Sudbury, ON

Paragon Alternative Medical Clinic

Amore Exotic Herbal Formula

Sexual enhancement

Labelled to contain yohimbe

Paris Natural Foods

1500 Paris Street

Sudbury, ON

Paris Natural Foods Vitamin D3 (4,000 IU)

 

Vitamin supplement

Labelled to contain prescription-strength vitamin D3

Paris Natural Foods

1500 Paris Street

Sudbury, ON

 

Durham Natural Foods

1191 Montrose Avenue Sudbury, ON

Paris Natural Foods Vitamin D3 (10,000 IU)

Vitamin supplement

Labelled to contain prescription-strength vitamin D3

Paris Natural Foods

1500 Paris Street

Sudbury, ON

 

Durham Natural Foods

1191 Montrose Avenue Sudbury, ON

Issue

Health Canada seized unauthorized health products from two natural food stores in Sudbury, Ontario, because the products are labelled to contain prescription or controlled drugs, which may pose serious health risks.

The unauthorized products include prescription-strength vitamin D3 supplements, hormones in capsule and cream format, and a sexual enhancement product.

Selling unauthorized health products in Canada is illegal. Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. For example, they could contain high-risk ingredients, such as prescription drugs, additives or contaminants that may or may not be listed on the label. These ingredients could interact with other medications and foods. In addition, these products may not actually contain the active ingredients that consumers would expect them to contain to help maintain and improve their health.

Prescription drugs should only be used under the advice and supervision of a health care professional because they are used to treat specific conditions and may cause serious side effects. Prescription drugs can only be legally sold with a prescription.

 What you should do

Background

Dehydroepiandrosterone (DHEA) is a controlled substance that can cause higher-than-normal levels of female and male hormones in the body and could increase the risk of prostate, breast, ovarian and other hormone-sensitive cancers. Potential side effects include serious cardiovascular disease, and changes in fertility and sperm production. DHEA should be avoided by individuals with a history of abnormal heart rhythms, blood clotting disorders, liver disease and those who are pregnant or breastfeeding.

Progesterone is a prescription drug and can be associated with serious side effects, particularly in patients at risk of blood clots. Patients who are taking progesterone-containing medications (such as birth control pills or hormone replacement therapy) may be at an increased risk due to their overall progesterone exposure. Health risks from the use of a progesterone cream would likely arise with long term use.

Vitamin D is considered a prescription drug when taken orally (by mouth) at doses of more than 2,500 International Units (IU) per day. Too much vitamin D can lead to vitamin D "intoxication," which can cause weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination, and muscle weakness. Pregnant people in particular should not take vitamin D exceeding the daily tolerable upper intake level for adults (4,000 IU). High levels of vitamin D taken during pregnancy can potentially lead to high calcium levels in the pregnant person, which can be associated with risks to the newborn.

Yohimbine is a prescription drug and should be used only under the supervision of a health care professional. Yohimbine is derived from yohimbe, a bark extract. The use of yohimbine or yohimbe may result in serious adverse reactions, particularly in people with high blood pressure or heart, kidney or liver disease. Side effects include increased blood pressure and heart rate, anxiety, dizziness, tremors, headache, nausea and sleep disorders. It should not be used by people who are pregnant or breastfeeding.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 21:15
The National Health IT Collaborative for the Underserved (NHIT), the first and oldest national non-profit focused on equitable access to health technology for underserved communities and communities of color, celebrated its 15th anniversary today...

at 21:00
The "Social Anxiety Disorder (SAD) - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The Social Anxiety Disorder (SAD) market report provides current treatment practices, emerging...

at 20:45
The "Global Continuous Glucose Monitoring Solutions Market, 2027 Forecast" report has been added to  ResearchAndMarkets.com's offering. Technological advancements and strategic partnerships create new opportunities for CGM vendors. The rising...

at 20:40
Researchers at Kanazawa University report in ACS Nano how ultrathin layers of tin disulfide can be used to accelerate the chemical reduction of carbon dioxide - a finding that is highly relevant for our quest towards a carbon-neutral society....

at 20:15
The "Regenerative Medicines: Bone and Joint Applications" report has been added to  ResearchAndMarkets.com's offering. The global market for regenerative medicine for bone and joint applications was valued at $9.6 billion in 2022. By technology, this...

at 20:10
The Canadian Animal Health Institute is thrilled to announce the winners of the inaugural ?Cutest Pets on Parliament Hill Contest'. Parliamentarians, Senators, staffers, and members of the Press Gallery on Parliament Hill, submitted more than 65...



News published on and distributed by: